StonvexLoading…
StonvexStonvexStonvexCore line items from CF's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.08B | $5.94B | $6.63B | $11.19B |
Operating Income | $2.30B | $1.75B | $2.23B | $5.40B |
Net Income | $1.80B | $1.48B | $1.84B | $3.94B |
EPS (Diluted) | $8.97 | $6.74 | $7.87 | $16.38 |
Total Assets | $14.09B | $13.47B | $14.38B | $13.31B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.98B | $1.61B | $2.03B | $2.32B |
Free Cash Flow OCF − CapEx | $1.80B | $1.75B | $2.26B | $3.40B |
Shares Outstanding | 153.55M | 169.88M | 188.19M | 195.60M |